HUMAN IL-23 ANTIGEN BINDING PROTEINS
First Claim
Patent Images
1. An isolated antigen binding protein that binds IL-23, comprising at least one heavy chain variable region comprising a CDRH1, a CDRH2 and a CDRH3 selected from the group consisting of:
- a) a CDRH1 that differs by no more than one amino acid substitution, insertion or deletion from a CDRH1 as shown in TABLE 3;
b) a CDRH2 that differs by no more than three amino acid substitutions, insertions and/or deletions from a CDRH2 as shown in TABLE 3;
c) a CDRH3 that differs by no more than three amino acid substitutions, insertions and/or deletions from a CDRH3 as shown in TABLE 3; and
comprising at least one light chain variable region comprising a CDRL1, a CDRL2 and a CDRL3 selected from the group consisting of;
d) a CDRL1 that differs by no more than three amino acid substitutions, insertions and/or deletions from a CDRL1 as shown in TABLE 3;
e) a CDRL2 that differs by no more than one amino acid substitution, insertion or deletion from a CDRL2 as shown in TABLE 3;
f) a CDRL3 that differs by no more than one amino acid substitution, insertion or deletion from a CDRL3 as shown in TABLE 3.
1 Assignment
0 Petitions
Accused Products
Abstract
Antigen binding proteins that bind to human IL-23 protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same as well as use of IL-23 antigen binding proteins for diagnostic and therapeutic purposes are also provided.
0 Citations
69 Claims
-
1. An isolated antigen binding protein that binds IL-23, comprising at least one heavy chain variable region comprising a CDRH1, a CDRH2 and a CDRH3 selected from the group consisting of:
-
a) a CDRH1 that differs by no more than one amino acid substitution, insertion or deletion from a CDRH1 as shown in TABLE 3; b) a CDRH2 that differs by no more than three amino acid substitutions, insertions and/or deletions from a CDRH2 as shown in TABLE 3; c) a CDRH3 that differs by no more than three amino acid substitutions, insertions and/or deletions from a CDRH3 as shown in TABLE 3; and comprising at least one light chain variable region comprising a CDRL1, a CDRL2 and a CDRL3 selected from the group consisting of; d) a CDRL1 that differs by no more than three amino acid substitutions, insertions and/or deletions from a CDRL1 as shown in TABLE 3; e) a CDRL2 that differs by no more than one amino acid substitution, insertion or deletion from a CDRL2 as shown in TABLE 3; f) a CDRL3 that differs by no more than one amino acid substitution, insertion or deletion from a CDRL3 as shown in TABLE 3. - View Dependent Claims (2, 3, 5, 6, 8, 9, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69)
-
-
4. An isolated antigen binding protein that binds IL-23 selected from the group consisting of
a) an antigen binding protein having CDRH1 of SEQ ID NO: - 129, CDRH2 of SEQ ID NO;
132, CDRH3 of SEQ ID NO;
136, and CDRL1 of SEQ ID NO;
123, CDRL2 of SEQ ID NO;
81, and CDRL3 of SEQ ID NO;
76;b) an antigen binding protein having CDRH1 of SEQ ID NO;
131, CDRH2 of SEQ ID NO;
134, CDRH3 of SEQ ID NO;
137 and CDRL1 of SEQ ID NO;
124, CDRL2 of SEQ ID N0126 and CDRL3 of SEQ ID NO;
128;c) a) an antigen binding protein having CDRH1 of SEQ ID NO;
130, CDRH2 of SEQ ID NO;
133, CDRH3 of SEQ ID NO;
99 and CDRL1 of SEQ ID NO;
68, CDRL2 of SEQ ID NO;
69, and CDRL3 of SEQ ID NO;
67; andd) an antigen binding protein having CDRH1 SEQ ID NO;
91, CDRH2 SEQ ID NO;
135, CDRH3 SEQ ID NO;
138 and CDRL1 SEQ ID NO;
125, CDRL2 SEQ ID NO;
127, and CDRL3 SEQ ID NO;
64.
- 129, CDRH2 of SEQ ID NO;
-
7. An isolated antigen binding protein that binds IL-23 comprising at least one heavy chain variable region and at least one light chain variable region, selected from the group consisting of:
-
a) a heavy chain variable region comprising amino acid residues 31-35, 50-65 and 99-113 of SEQ ID NO;
31; anda light chain variable region comprising amino acid residues 23-36, 52-58 and 91-101 of SEQ ID NO;
1;b) a heavy chain variable region comprising amino acid residues 31-35, 50-65 and 99-110 of SEQ ID NO;
34 and heavy chain variable region comprising amino acid residues 31-35, 50-66 and 99-110 of SEQ ID NO;
36; anda light chain variable region comprising amino acid residues 23-36, 52-62 and 97-105 of SEQ ID NO;
4;c) a heavy chain variable region comprising amino acid residues 31-35, 50-66 and 99-114 of SEQ ID NO;
38; anda light chain variable region comprising amino acid residues 23-34, 50-61 and 94-106 of SEQ ID NO;
7;d) a heavy chain variable region comprising amino acid residues 31-35, 50-66 and 99-114 of SEQ ID NO;
40; anda light chain variable region comprising amino acid residues 24-34, 50-56 and 94-106 of SEQ ID NO;
9;e) a heavy chain variable region comprising amino acid residues 31-35, 50-66 and 99-114 of SEQ ID NO;
42; anda light chain variable region comprising amino acid residues 23-34, 50-61 and 94-106 of SEQ ID NO;
11;f) a heavy chain variable region comprising amino acid residues 31-35, 50-65 and 98-107 of SEQ ID NO;
44; anda light chain variable region comprising amino acid residues 24-34, 50-56 and 89-97 of SEQ ID NO;
13;g) a heavy chain variable region comprising amino acid residues 31-37, 52-67 and 100-109 of SEQ ID NO;
46 or 153; anda light chain variable region comprising amino acid residues 24-34, 50-56 and 89-97 of SEQ ID NO15; h) a heavy chain variable region comprising amino acid residues 31-37, 52-67 and 100-109 of SEQ ID NO;
48; anda light chain variable region comprising amino acid residues 24-34, 50-56 and 89-97 of SEQ ID NO;
17;i) a heavy chain variable region comprising amino acid residues 31-37, 52-67 and 101-109 of SEQ ID NO;
50; anda light chain variable region comprising amino acid residues 24-34, 50-56 and 89-97 of SEQ ID NO;
19;j) a heavy chain variable region comprising amino acid residues 31-35, 50-65 and 98-107 of SEQ ID NO;
52; anda light chain variable region comprising amino acid residues 24-34, 50-56 and 98-107 of SEQ ID NO;
21;k) a heavy chain variable region comprising amino acid residues 31-37, 52-67 and 100-109 of SEQ ID NO;
54; anda light chain variable region comprising amino acid residues 24-34, 50-56 and 89-97 of SEQ ID NO;
23;l) a heavy chain variable region comprising amino acid residues 31-37, 52-67 and 100-109 of SEQ ID NO;
56; anda light chain variable region comprising amino acid residues 24-34, 50-56 and 89-97 of SEQ ID NO;
25; andm) a heavy chain variable region comprising amino acid residues 31-37, 52-57 and 100-109 of SEQ ID NO;
58; anda light chain variable region comprising amino acid residues 24-34, 500-56 and 89-97 of SEQ ID NO;
27.
-
-
10. An isolated antigen binding protein that binds IL-23 comprising a heavy chain variable region and a light chain variable region, wherein the heavy chain variable region sequence differs by no more than 13 amino acid substitutions, additions and/or deletions from a heavy chain variable region sequence as shown in TABLE 2;
- and wherein the light chain variable region sequence differs by no more than 13 amino acid substitutions, additions and/or deletions from a light chain variable region sequence as shown in TABLE 1.
- View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18)
-
19. An isolated antigen binding protein that binds IL-23 selected from the group consisting of
a) a heavy chain variable region of SEQ ID NO: - 140 and a light chain variable region of SEQ ID NO;
30;b) a heavy chain variable region of SEQ ID NO;
141 and a light chain variable region of SEQ ID NO;
61;c) a heavy chain variable region of SEQ ID NO;
142 and a light chain variable region of SEQ ID NO;
4; andd) a heavy chain variable region of SEQ ID NO;
143 and a light chain variable region of SEQ ID NO;
139.
- 140 and a light chain variable region of SEQ ID NO;
-
20. An isolated antigen binding protein that binds IL-23 comprising
a heavy chain variable region comprising of an amino acid sequence having at least 90% sequence identity to SEQ ID NO: - 31, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56 and 58; and
a light chain variable region comprising an amino acid sequence having at least 90% sequence identity to SEQ ID NO;
1, 4, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25 and 27. - View Dependent Claims (21, 22, 23, 24, 25)
- 31, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56 and 58; and
-
26. An isolated antigen binding protein that binds IL-23 comprising a heavy chain variable region and a light chain variable region selected from the group consisting of:
-
a) a heavy chain variable region of SEQ ID NO;
31 and a light chain variable region of SEQ ID NO;
1;b) a heavy chain variable region of SEQ ID NO;
34 or 36 and a light chain variable region of SEQ ID NO;
4;c) a heavy chain variable region of SEQ ID NO;
38 and a light chain variable region of SEQ ID NO;
7;d) a heavy chain variable region of SEQ ID NO;
40 and a light chain variable region of SEQ ID NO;
9;e) a heavy chain variable region of SEQ ID NO;
42 and a light chain variable region of SEQ ID NO;
11;f) a heavy chain variable region of SEQ ID NO;
44 and a light chain variable region of SEQ ID NO;
13;g) a heavy chain variable region of SEQ ID NO;
46 or 153 and a light chain variable region of SEQ ID NO;
15;h) a heavy chain variable region of SEQ ID NO;
48 and a light chain variable region of SEQ ID NO;
17;i) a heavy chain variable region of SEQ ID NO;
50 and a light chain variable region of SEQ ID NO;
19;j) a heavy chain variable region of SEQ ID NO;
52 and a light chain variable region of SEQ ID NO;
21;k) a heavy chain variable region of SEQ ID NO;
54 and a light chain variable region of SEQ ID NO;
23;l) a heavy chain variable region of SEQ ID NO;
56 and a light chain variable region of SEQ ID NO;
25; andm) a heavy chain variable region of SEQ ID NO;
58 and a light chain variable region of SEQ ID NO;
27.
-
-
27. An isolated antigen binding protein that binds human IL-23, wherein the covered patch formed when said antigen binding protein is bound to human IL-23 comprises residue contacts 30, 31, 32, 49, 50, 52, 53, 56, 92 and 94 of SEQ ID NO:
- 15, wherein said residue contacts have a difference value of greater than or equal to 10 Å
2 as determined by solvent exposed surface area.
- 15, wherein said residue contacts have a difference value of greater than or equal to 10 Å
-
28. An isolated antigen binding protein that binds human IL-23, wherein the covered patch formed when said antigen binding protein is bound to human IL-23 comprises residue contacts 31-35, 54, 58-60, 66, and 101-105 of SEQ ID NO:
- 46, wherein said residue contacts have a difference value of greater than or equal to 10 Å
2 as determined by solvent exposed surface area.
- 46, wherein said residue contacts have a difference value of greater than or equal to 10 Å
-
29. An isolated antigen binding protein that binds human IL-23, wherein the covered patch formed when said antigen binding protein is bound to human IL-23 comprises residue contacts 31-34, 51, 52, 55, 68, 93 and 98 of SEQ ID NO:
- 1, wherein said residue contacts have a difference value of greater than or equal to 10 Å
2 as determined by solvent exposed surface area.
- 1, wherein said residue contacts have a difference value of greater than or equal to 10 Å
-
30. An isolated antigen binding protein that binds human IL-23, wherein the covered patch formed when said antigen binding protein is bound to human IL-23 comprises residue contacts 1, 26, 28, 31, 32, 52, 53, 59, 76, 101, 102 and 104-108 of SEQ ID NO:
- 31, wherein said residue contacts have a difference value of greater than or equal to 10 Å
2 as determined by solvent exposed surface area.
- 31, wherein said residue contacts have a difference value of greater than or equal to 10 Å
-
31. An isolated antigen binding protein that binds human IL-23, wherein when said antigen binding protein is bound to human IL-23, said antigen binding protein is 5 Å
- or less from residues 32-35, 54, 58-60, 66 and 101-105 of SEQ ID NO;
46, as determined by X-ray crystallography. - View Dependent Claims (32)
- or less from residues 32-35, 54, 58-60, 66 and 101-105 of SEQ ID NO;
-
33. An isolated antigen binding protein that binds human IL-23, wherein when said antigen binding protein is bound to human IL-23, said antigen binding protein is 5 Å
- or less from residues 30-32, 49, 52, 53, 91-94 and 96 of SEQ ID NO;
1 5, as determined by X-ray crystallography. - View Dependent Claims (34)
- or less from residues 30-32, 49, 52, 53, 91-94 and 96 of SEQ ID NO;
-
35. An isolated antigen binding protein that binds human IL-23, wherein when said antigen binding protein is bound to human IL-23, said antigen binding protein is 5 Å
- or less from residues 26-28, 31, 53, 59, 102 and 104-108 of SEQ ID NO;
31, as determined by X-ray crystallography. - View Dependent Claims (36)
- or less from residues 26-28, 31, 53, 59, 102 and 104-108 of SEQ ID NO;
-
37. An isolated antigen binding protein that binds human IL-23, wherein when said antigen binding protein is bound to human IL-23, said antigen binding protein is 5 Å
- or less from residues 31-34, 51, 52, 55, 68 and 93 of SEQ ID NO;
1 as determined by X-ray crystallography. - View Dependent Claims (38)
- or less from residues 31-34, 51, 52, 55, 68 and 93 of SEQ ID NO;
-
54. An isolated antigen binding protein that binds human IL-23, wherein the covered patch formed when said antigen binding protein is bound to human IL-23 comprises a residue contact within residues 46-58, a residue contact within residues 112-120, and a residue contact within residues 155-163 of the human IL-23p19 subunit as described in SEQ ID NO:
- 145, wherein said residue contact has a difference value greater than or equal to 10 Å
2 as determined by solvent exposed surface area. - View Dependent Claims (55)
- 145, wherein said residue contact has a difference value greater than or equal to 10 Å
-
56. An isolated antigen binding protein that binds human IL-23, wherein when said antigen binding protein is bound to human IL-23 said antigen binding protein is 5 Å
- or less from a residue within residues 46-58, from a residue within residues 112-123, and from a residue within residues 155-163 of the human IL-23p19 subunit as described in SEQ ID NO;
145, as determined by X-ray crystallography. - View Dependent Claims (57)
- or less from a residue within residues 46-58, from a residue within residues 112-123, and from a residue within residues 155-163 of the human IL-23p19 subunit as described in SEQ ID NO;
Specification